Prebiotic Fibre and Butyrate: What Happens After Gut Bacteria Ferment Fibre?

When people hear that fibre can support butyrate production, it can sound as though butyrate is already sitting inside the fibre waiting to be released. It is not. Fibre is closer to raw material. Gut microbes do the converting, and what they make depends on the fibre, the microbes present and how those microbes work together.

Butyrate is a short-chain fatty acid that can be produced when gut bacteria ferment suitable substrates. Some fermentable fibres can contribute to that process, but different fibres can lead to different fermentation patterns and different amounts of acetate, propionate and butyrate. That is why prebiotic fibre and butyrate are connected, but they are not the same thing.

If you are looking at the bigger picture of food, prebiotics and everyday gut support, our Gut Health Reset brings those pieces together in one place.

Fibre is the starting material, not the finished product

Our own digestive enzymes can break down many carbohydrates, proteins and fats. Some dietary fibres resist that digestion and remain available for microbes living in the large intestine.

That makes fibre a substrate, or food source, for microbial activity. It does not mean every fibre behaves the same way. Fibre structure matters. The same is true for pectin, resistant starch, inulin-type fructans and other fermentable carbohydrates. Their chemistry affects which microbes can use them and what happens during fermentation.

This is also why the phrase fibre fermentation butyrate needs a little context. The fibre is not opening up and releasing a stored dose of butyrate. Microbes are using the substrate and producing metabolites as part of their own metabolism.

Gut microbes do the converting

Fermentation is simply what happens when microbes use certain food components for energy and growth in an environment with little oxygen. During that activity, they can produce compounds including short-chain fatty acids.

The main short-chain fatty acids discussed in gut research are acetate, propionate and butyrate. Butyrate is one possible end product, not the inevitable result of every fermentable fibre.

Which metabolites appear, and in what amounts, depends on factors such as the substrate, the microbial community, the local conditions and the other compounds available. Two people can eat the same fibre and still have different fermentation responses.

That is one reason we prefer to talk about supporting microbial activity rather than promising a fixed butyrate result from a particular food or supplement.

Microbes rarely work alone

A gut microbial community is more like a busy neighbourhood than a single factory. One organism may break down part of a complex carbohydrate. Another may use the smaller compounds that become available. A third may use acetate or lactate produced by its neighbours and turn those compounds into something else.

This kind of microbial cross-feeding has been demonstrated between Bifidobacterium adolescentis and Faecalibacterium prausnitzii. In laboratory co-cultures, the presence of the bifidobacterium was associated with higher butyrate production by F. prausnitzii than F. prausnitzii produced alone under the same tested conditions.

The useful point is not that everyone needs those exact two organisms. It is that fibre-to-butyrate chemistry can involve several members of the community. That makes the result more complex than a one-fibre, one-bacterium, one-metabolite story.

Where Faecalibacterium prausnitzii fits into the picture

Faecalibacterium prausnitzii, often shortened to F. prausnitzii or F. prau, is a well-recognised butyrate-producing bacterium found in the human gut. Researchers are interested in it because it is common in many healthy gut communities, can use certain carbohydrate substrates and is linked to butyrate production.

Laboratory research has also shown that cultured F. prausnitzii strains can use apple pectin and pectin-derived compounds for growth. That helps explain why pectin-rich ingredients are interesting in prebiotic research, although it does not mean every pectin produces the same result in every gut.

We do not treat F. prausnitzii as a score for overall gut health, and we do not think everyone should simply aim to maximise one bacterium. It is one useful part of a much larger microbial community.

It is also one reason we are interested in the Livaux gold kiwifruit ingredient used in our Kiwifruit Extract Prebiotic + Enzyme Formula. Human Livaux research has measured changes in F. prausnitzii, which gives us a specific bacterial endpoint to discuss without pretending that endpoint tells us everything about the microbiome.

More F. prausnitzii is not the same measurement as more butyrate

This distinction matters. Researchers can measure the relative abundance or number of a bacterium, and they can separately measure the concentration or production of a metabolite such as butyrate. Those are connected biological questions, but they are not interchangeable.

A study might find more F. prausnitzii in faecal samples. That tells us something about the measured bacterial population. It does not, by itself, prove that the person produced more butyrate.

Likewise, a study can measure more butyrate without proving that one particular bacterium caused the increase. Other butyrate-producing bacteria and cross-feeding relationships may also be involved.

Measurement adds another layer. Faecal bacterial abundance, faecal butyrate concentration and total butyrate production are not identical measurements. Butyrate can be produced and used within the gut before a stool sample is collected, so a stool concentration is not a complete tally of everything that was produced.

For practical reading of research, the safest question is simple: what did the researchers actually measure? If they measured a bacterium, we should report a bacterial result. If they measured butyrate, we can report a butyrate result.

What Our Livaux Evidence Shows, and What It Does Not Show About Butyrate

Our current Kiwifruit Extract formula uses NZ-grown Livaux gold kiwifruit powder as the prebiotic side of the formula. Each capsule contains 300 mg Livaux. Our daily serving is two capsules, supplying 600 mg Livaux gold kiwifruit powder.

The formula separately contains 250 mg NZ-grown OxiFend green kiwifruit enzyme extract per capsule. Two capsules supply 500 mg green kiwifruit enzyme extract and 12,500 CDU of declared actinidin activity. The green ingredient has the separate enzyme role. We do not use OxiFend as the basis of the Livaux prebiotic or butyrate story.

If you want the broader explanation of why we keep the gold prebiotic ingredient and green enzyme ingredient separate, see our guide to kiwifruit extract benefits for digestion.

The most relevant human Livaux study here is a 2025 randomised, double-blind, placebo-controlled trial. It tested 600 mg Livaux daily for 28 days, the same daily quantity of Livaux supplied by our current two-capsule serving. The study reported an increase in faecal F. prausnitzii relative abundance in the Livaux group, along with digestive outcomes including bowel and bloating measures.

That is useful evidence for our interest in this named gold kiwifruit ingredient. It is also important to keep the boundary clear: the study tested Livaux, not our complete Kiwi Superfoods gold-plus-green formula. We therefore do not claim that the finished formula has been clinically proven to increase F. prausnitzii.

For this article, there is an even more important boundary. The 2025 human trial gives us a human F. prausnitzii result. It should not be presented as proof that human butyrate increased unless butyrate itself was directly measured as an endpoint. More F. prausnitzii is not a substitute for measuring butyrate.

The 2025 research was jointly funded by Anagenix and AIDP. That funding context is worth knowing alongside the study design and results.

There is also separate in-vitro evidence from an M-SHIME gut model in which Livaux and Actazin were included as part of a multi-ingredient synbiotic containing other prebiotic components and probiotics. That model reported increased butyrate across simulated colon compartments. Because several ingredients were present, and because this was an artificial gut model rather than a human trial, we do not attribute that butyrate result to Livaux alone or merge it with the 2025 human findings.

This separation is exactly why named ingredients and measured endpoints matter. Human evidence for a bacterial change is useful. In-vitro evidence for a metabolite change can also be useful. They answer different questions.

Why a varied fibre-rich diet still matters

A targeted prebiotic ingredient does not replace a varied fibre-rich diet. Different plant foods bring different fibres, resistant carbohydrates, polyphenols and other compounds to the gut. That variety gives microbial communities a wider mix of substrates to work with.

Think vegetables, fruit, legumes, whole grains, nuts and seeds in combinations that suit you. There is no need to chase one food simply because it appears on a list of possible butyrate-supporting fibres.

Our formula offers something different: a convenient, measured amount of a named NZ-grown gold kiwifruit prebiotic ingredient, paired with a separate actinidin-containing green kiwifruit enzyme extract. If you want a simple refresher on the differences between these categories, our prebiotics, probiotics and digestive enzymes guide keeps them easy to separate.

And if you are comparing broader supplement options rather than one ingredient, our guide to the best gut health supplements in NZ explains the different jobs these products can be designed to do.

Common questions

What is butyrate?

Butyrate is a short-chain fatty acid and microbial metabolite. Gut bacteria can produce it when they ferment suitable substrates, including some fermentable fibres and fibre-derived compounds.

How do gut bacteria make butyrate from fibre?

Gut microbes ferment fibre and other available substrates for energy and growth. Different organisms can break down different parts of the substrate, exchange metabolites through cross-feeding and, in some cases, produce butyrate as an end product.

Which fibres can lead to butyrate production?

Fermentable fibres such as some resistant starches, inulin-type fructans and pectins can contribute to butyrate production under suitable microbial conditions. The amount produced varies with fibre structure, dose, the microbial community and other conditions in the gut.

What bacteria make butyrate?

Several gut bacteria can produce butyrate, including species within genera such as Faecalibacterium, Roseburia, Anaerostipes and Eubacterium. The gut works as a community, so butyrate production should not be reduced to one bacterial name.

Does Faecalibacterium prausnitzii produce butyrate?

Yes. F. prausnitzii is recognised as a butyrate-producing gut bacterium. It can use certain carbohydrate substrates, including some pectins, but its abundance alone does not tell us exactly how much butyrate a person is producing.

Does pectin produce butyrate?

Pectin does not produce butyrate by itself. Gut microbes can ferment some pectins and generate short-chain fatty acids, which may include butyrate. Research also shows that different pectins and different microbial communities can produce different fermentation results.

Can a prebiotic supplement increase butyrate?

Potentially, yes, if the prebiotic supplies a substrate that supports microbial activity leading to butyrate production. The result depends on the ingredient and the person. For our Livaux ingredient, the 2025 human trial showed increased F. prausnitzii, but that bacterial result should not be treated as direct proof of increased human butyrate.

Is butyrate a prebiotic or a postbiotic?

Butyrate is a microbial metabolite and short-chain fatty acid. It is not a prebiotic, because a prebiotic is a substrate used by host microorganisms. Under the ISAPP consensus definition, a postbiotic is a preparation of inanimate microorganisms and/or their components that confers a health benefit, so isolated butyrate is not automatically a postbiotic on its own.

Does more Faecalibacterium prausnitzii always mean more butyrate?

No. F. prausnitzii can produce butyrate, but bacterial abundance and butyrate concentration or production are different measurements. Other microbes, substrate availability, cross-feeding and butyrate use within the gut can all affect the final measurement.

Does Kiwi Superfoods Kiwifruit Extract contain butyrate?

No. Butyrate is not listed as an ingredient in our formula. Our Kiwifruit Extract instead contains Livaux gold kiwifruit as the prebiotic ingredient plus a separate actinidin-containing OxiFend green kiwifruit extract. It is not a direct butyrate supplement.

Next steps

If your interest is in a targeted prebiotic ingredient with human evidence for increasing F. prausnitzii at 600 mg daily, our Kiwifruit Extract Prebiotic + Enzyme Formula is worth considering. Our current two-capsule serving supplies that same 600 mg daily amount of Livaux, alongside a separate NZ-grown green kiwifruit enzyme extract.

That gives the formula a clear two-part purpose: Livaux on the prebiotic side, OxiFend on the enzyme side. It does not turn the finished formula into a proven human butyrate supplement, and it does not need to. The value is in using a named NZ-grown prebiotic ingredient at the same daily amount studied in the 2025 Livaux trial, while keeping the evidence precise.

You can see the full ingredients, serving details and current product information on our Kiwifruit Extract Prebiotic + Enzyme Formula page.

A quick safety note: the formula contains kiwifruit. Always read the label and use as directed. If you are pregnant or lactating, seek professional health advice before taking this dietary supplement. A supplement is designed to complement, not replace, a varied diet.

References

1. McKeen S, Henning SM, Lewis E, et al. Livaux gold kiwifruit powder consumption at 600 mg per day for 28 days increases Faecalibacterium prausnitzii numbers and decreases bloating and hydrogenotrophic species numbers in healthy individuals, consistent with slow fermentation: a randomized controlled trial. Bioactive Carbohydrates and Dietary Fibre. 2025;33:100468. https://doi.org/10.1016/j.bcdf.2025.100468
2. Rios-Covian D, Gueimonde M, Duncan SH, Flint HJ, de los Reyes-Gavilan CG. Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiology Letters. 2015;362(21):fnv176. https://doi.org/10.1093/femsle/fnv176
3. Lopez-Siles M, Khan TM, Duncan SH, Harmsen HJM, Garcia-Gil LJ, Flint HJ. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Applied and Environmental Microbiology. 2012;78(2):420-428. https://doi.org/10.1128/AEM.06858-11
4. Bang SJ, Kim G, Lim MY, et al. The influence of in vitro pectin fermentation on the human fecal microbiome. AMB Express. 2018;8:98. https://doi.org/10.1186/s13568-018-0629-9
5. Gibson GR, Hutkins R, Sanders ME, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology. 2017;14:491-502. https://doi.org/10.1038/nrgastro.2017.75
6. Salminen S, Collado MC, Endo A, et al. The International Scientific Association of Probiotics and Prebiotics consensus statement on the definition and scope of postbiotics. Nature Reviews Gastroenterology & Hepatology. 2021;18:649-667. https://doi.org/10.1038/s41575-021-00440-6
7. Livaux. Microbiome Labs synbiotic formulation with Livaux and Actazin increases Faecalibacterium prausnitzii in the M-SHIME gut model. In-vitro multi-ingredient model report. https://livaux.com/livaux-actazin-good-gut-bacterium/